[3] GLP-1 receptor agonists like liraglutide and semaglutide have transformed the health profiles of people with diabetes, obesity, or a high body mass index with weight-related health issues
Medication is paid quarterly
Ischemic strokes can also be caused by a blood clot that forms elsewhere in the body and travels to the brain (embolic stroke)
Clinical trials reported in the European Public Assessment Report (EPAR) showed nausea affecting approximately 44% of patients, diarrhoea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), and dyspepsia (9%)
Semaglutide helps reduce appetite and cravings, making it easier to consume fewer calories without feeling deprived
It is important to distinguish between side effects directly attributable to the medication's pharmacological action and those arising from the broader context of weight management